Review



λ dna  (TaKaRa)


Bioz Verified Symbol TaKaRa is a verified supplier
Bioz Manufacturer Symbol TaKaRa manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 93
      Buy from Supplier

    Structured Review

    TaKaRa λ dna
    a Human plasma experiment schematic. b <t>Plasma</t> <t>λ</t> <t>DNA</t> levels were measured at various time-points (0, 1, 7 and 14 days) by real-time PCR (n=3). Final plasma concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. c Plasma MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final plasma concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. d Human urine experiment schematic. e Urine λ DNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD. f Urine MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD.
    λ Dna, supplied by TaKaRa, used in various techniques. Bioz Stars score: 93/100, based on 327 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/λ dna/product/TaKaRa
    Average 93 stars, based on 327 article reviews
    λ dna - by Bioz Stars, 2026-02
    93/100 stars

    Images

    1) Product Images from "Universal nucleic acid preservation in biological fluids with boron clusters"

    Article Title: Universal nucleic acid preservation in biological fluids with boron clusters

    Journal: bioRxiv

    doi: 10.64898/2026.01.13.697153

    a Human plasma experiment schematic. b Plasma λ DNA levels were measured at various time-points (0, 1, 7 and 14 days) by real-time PCR (n=3). Final plasma concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. c Plasma MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final plasma concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. d Human urine experiment schematic. e Urine λ DNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD. f Urine MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD.
    Figure Legend Snippet: a Human plasma experiment schematic. b Plasma λ DNA levels were measured at various time-points (0, 1, 7 and 14 days) by real-time PCR (n=3). Final plasma concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. c Plasma MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final plasma concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. d Human urine experiment schematic. e Urine λ DNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD. f Urine MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD.

    Techniques Used: Clinical Proteomics, Real-time Polymerase Chain Reaction, Concentration Assay



    Similar Products

    λ dna  (New England Biolabs)
    97
    New England Biolabs λ dna
    λ Dna, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/λ dna/product/New England Biolabs
    Average 97 stars, based on 1 article reviews
    λ dna - by Bioz Stars, 2026-02
    97/100 stars
    		  Buy from Supplier
    λ dna  (TaKaRa)
    93
    TaKaRa λ dna
    a Human plasma experiment schematic. b <t>Plasma</t> <t>λ</t> <t>DNA</t> levels were measured at various time-points (0, 1, 7 and 14 days) by real-time PCR (n=3). Final plasma concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. c Plasma MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final plasma concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. d Human urine experiment schematic. e Urine λ DNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD. f Urine MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD.
    λ Dna, supplied by TaKaRa, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/λ dna/product/TaKaRa
    Average 93 stars, based on 1 article reviews
    λ dna - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    lambda dna  (New England Biolabs)
    96
    New England Biolabs lambda dna
    a Human plasma experiment schematic. b <t>Plasma</t> <t>λ</t> <t>DNA</t> levels were measured at various time-points (0, 1, 7 and 14 days) by real-time PCR (n=3). Final plasma concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. c Plasma MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final plasma concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. d Human urine experiment schematic. e Urine λ DNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD. f Urine MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD.
    Lambda Dna, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lambda dna/product/New England Biolabs
    Average 96 stars, based on 1 article reviews
    lambda dna - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    biotinylated lambda dna lumicks  (New England Biolabs)
    96
    New England Biolabs biotinylated lambda dna lumicks
    a Human plasma experiment schematic. b <t>Plasma</t> <t>λ</t> <t>DNA</t> levels were measured at various time-points (0, 1, 7 and 14 days) by real-time PCR (n=3). Final plasma concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. c Plasma MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final plasma concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. d Human urine experiment schematic. e Urine λ DNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD. f Urine MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD.
    Biotinylated Lambda Dna Lumicks, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/biotinylated lambda dna lumicks/product/New England Biolabs
    Average 96 stars, based on 1 article reviews
    biotinylated lambda dna lumicks - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    stop buffer  (New England Biolabs)
    96
    New England Biolabs stop buffer
    a Human plasma experiment schematic. b <t>Plasma</t> <t>λ</t> <t>DNA</t> levels were measured at various time-points (0, 1, 7 and 14 days) by real-time PCR (n=3). Final plasma concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. c Plasma MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final plasma concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. d Human urine experiment schematic. e Urine λ DNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD. f Urine MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD.
    Stop Buffer, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/stop buffer/product/New England Biolabs
    Average 96 stars, based on 1 article reviews
    stop buffer - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier
    bacteriophage λ dna  (New England Biolabs)
    97
    New England Biolabs bacteriophage λ dna
    a Human plasma experiment schematic. b <t>Plasma</t> <t>λ</t> <t>DNA</t> levels were measured at various time-points (0, 1, 7 and 14 days) by real-time PCR (n=3). Final plasma concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. c Plasma MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final plasma concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. d Human urine experiment schematic. e Urine λ DNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD. f Urine MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD.
    Bacteriophage λ Dna, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bacteriophage λ dna/product/New England Biolabs
    Average 97 stars, based on 1 article reviews
    bacteriophage λ dna - by Bioz Stars, 2026-02
    97/100 stars
    		  Buy from Supplier
    λ dna hindiii digest  (New England Biolabs)
    93
    New England Biolabs λ dna hindiii digest
    a Human plasma experiment schematic. b <t>Plasma</t> <t>λ</t> <t>DNA</t> levels were measured at various time-points (0, 1, 7 and 14 days) by real-time PCR (n=3). Final plasma concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. c Plasma MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final plasma concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. d Human urine experiment schematic. e Urine λ DNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD. f Urine MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD.
    λ Dna Hindiii Digest, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/λ dna hindiii digest/product/New England Biolabs
    Average 93 stars, based on 1 article reviews
    λ dna hindiii digest - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    lambda phage dna  (Jena Bioscience)
    94
    Jena Bioscience lambda phage dna
    a Human plasma experiment schematic. b <t>Plasma</t> <t>λ</t> <t>DNA</t> levels were measured at various time-points (0, 1, 7 and 14 days) by real-time PCR (n=3). Final plasma concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. c Plasma MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final plasma concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. d Human urine experiment schematic. e Urine λ DNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD. f Urine MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD.
    Lambda Phage Dna, supplied by Jena Bioscience, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lambda phage dna/product/Jena Bioscience
    Average 94 stars, based on 1 article reviews
    lambda phage dna - by Bioz Stars, 2026-02
    94/100 stars
    		  Buy from Supplier
    lambda phage dna  (New England Biolabs)
    96
    New England Biolabs lambda phage dna
    a Human plasma experiment schematic. b <t>Plasma</t> <t>λ</t> <t>DNA</t> levels were measured at various time-points (0, 1, 7 and 14 days) by real-time PCR (n=3). Final plasma concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. c Plasma MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final plasma concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. d Human urine experiment schematic. e Urine λ DNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD. f Urine MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD.
    Lambda Phage Dna, supplied by New England Biolabs, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/lambda phage dna/product/New England Biolabs
    Average 96 stars, based on 1 article reviews
    lambda phage dna - by Bioz Stars, 2026-02
    96/100 stars
    		  Buy from Supplier

    Image Search Results


    a Human plasma experiment schematic. b Plasma λ DNA levels were measured at various time-points (0, 1, 7 and 14 days) by real-time PCR (n=3). Final plasma concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. c Plasma MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final plasma concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. d Human urine experiment schematic. e Urine λ DNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD. f Urine MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD.

    Journal: bioRxiv

    Article Title: Universal nucleic acid preservation in biological fluids with boron clusters

    doi: 10.64898/2026.01.13.697153

    Figure Lengend Snippet: a Human plasma experiment schematic. b Plasma λ DNA levels were measured at various time-points (0, 1, 7 and 14 days) by real-time PCR (n=3). Final plasma concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. c Plasma MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final plasma concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in plasma is as indicated. Bars represent group mean ± SD. d Human urine experiment schematic. e Urine λ DNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentration of [B 12 H 12 ] 2- is 0.25 M, and the initial λ DNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD. f Urine MS2 ssRNA levels were measured at various time-points (0, 1, 3, 7 and 14 days) by real-time PCR (n=3). Final urine concentrations of [B 12 H 12 ] 2- , SUPERase.In and RNase inhibitor are 0.25 M, 2U/μL and 4U/μL, respectively. The initial MS2 ssRNA spike-in concentration in urine is as indicated. Bars represent group mean ± SD.

    Article Snippet: RNase inhibitor was purchased from Molecular Cloning Laboratories (cat no. RNIN200). λ DNA-HindIII Digest (cat no. N3012) and dsRNA Ladder (cat no. N0363S) were purchased from New England BioLabs. λ DNA was purchased from Takara Bio (cat no. 3010). ssRNA was purchased from Millipore (cat no. 55714). tRNA (cat no. 10109495001) and MS2 single-stranded RNA genome (cat no. 10165948001) were purchased from Roche.

    Techniques: Clinical Proteomics, Real-time Polymerase Chain Reaction, Concentration Assay